CXCR4 and osteosarcoma: Thus far, there is insufficient evidence on the role of 68Ga-Pentixafor in osteosarcoma; however, from the published data on immunohistochemistry, this tracer may have a role in prognosis and selecting patients who may benefit from therapies targeting CXCR4.